Page last updated: 2024-08-17

desoxycorticosterone and eplerenone

desoxycorticosterone has been researched along with eplerenone in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (44.44)29.6817
2010's3 (33.33)24.3611
2020's2 (22.22)2.80

Authors

AuthorsStudies
Funder, JW1
Dilley, R; Funder, JW; Moussa, L; Young, MJ1
Funder, JW; Young, M1
Fuller, PJ; Funder, JW; Morgan, J; Rickard, AJ; Young, MJ1
Chasiotis, H; Kelly, SP1
Cassis, LA; Daugherty, A; Gong, MC; Guo, Z; Liu, S; Pearson, KJ; Xie, Z1
Bernhardt, R; Brixius-Anderko, S; Hannemann, F; Hobler, A; Müller, AR; Schiffer, L; Zapp, J1
Baker, ME; Hyodo, S; Katsu, Y; Lin, X; Oana, S1
Aedo, JE; Aravena-Canales, D; Molina, A; Osorio-Fuentealba, C; Valdés, JA; Zuloaga, R1

Reviews

1 review(s) available for desoxycorticosterone and eplerenone

ArticleYear
New biology of aldosterone, and experimental studies on the selective aldosterone blocker eplerenone.
    American heart journal, 2002, Volume: 144, Issue:5 Suppl

    Topics: Aldosterone; Animals; Cardiomegaly; Clinical Trials as Topic; Desoxycorticosterone; Eplerenone; Fibrosis; Heart; Heart Failure; Humans; Hypertension; Mineralocorticoid Receptor Antagonists; Myocardium; Rats; Rats, Inbred SHR; Receptors, Mineralocorticoid; Spironolactone

2002

Other Studies

8 other study(ies) available for desoxycorticosterone and eplerenone

ArticleYear
Early inflammatory responses in experimental cardiac hypertrophy and fibrosis: effects of 11 beta-hydroxysteroid dehydrogenase inactivation.
    Endocrinology, 2003, Volume: 144, Issue:3

    Topics: 11-beta-Hydroxysteroid Dehydrogenases; Animals; Blood Pressure; Carbenoxolone; Cardiomegaly; Coronary Disease; Desoxycorticosterone; Enzyme Inhibitors; Eplerenone; Fibrosis; Heart; Hydroxysteroid Dehydrogenases; Kidney; Male; Mineralocorticoid Receptor Antagonists; Muscle, Smooth, Vascular; Myocardium; Nephrectomy; Organ Size; Rats; Rats, Sprague-Dawley; Sodium Chloride; Solutions; Spironolactone; Vasculitis

2003
Eplerenone, but not steroid withdrawal, reverses cardiac fibrosis in deoxycorticosterone/salt-treated rats.
    Endocrinology, 2004, Volume: 145, Issue:7

    Topics: Animals; Biomarkers; Coronary Vessels; Desoxycorticosterone; Eplerenone; Fibrosis; Male; Mineralocorticoid Receptor Antagonists; Myocardium; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Sodium Chloride, Dietary; Spironolactone; Vasculitis

2004
Does glucocorticoid receptor blockade exacerbate tissue damage after mineralocorticoid/salt administration?
    Endocrinology, 2007, Volume: 148, Issue:10

    Topics: Animals; Biomarkers; Blood Pressure; Cardiomegaly; Cardiomyopathies; Coronary Vessels; Desoxycorticosterone; Drug Administration Schedule; Eplerenone; Fibrosis; Hormone Antagonists; Male; Mifepristone; Myocardium; Organ Size; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptors, Glucocorticoid; Signal Transduction; Sodium Chloride; Spironolactone; Vasculitis

2007
Glucocorticoid and mineralocorticoid receptors regulate paracellular permeability in a primary cultured gill epithelium.
    The Journal of experimental biology, 2011, Jul-15, Volume: 214, Issue:Pt 14

    Topics: Aldosterone; Animals; Cell Membrane Permeability; Cells, Cultured; Desoxycorticosterone; Dexamethasone; Electric Impedance; Epithelial Cells; Epithelium; Eplerenone; Fish Proteins; Gene Expression Regulation; Gills; Hydrocortisone; Mifepristone; Mineralocorticoid Receptor Antagonists; Oncorhynchus mykiss; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spironolactone; Tight Junctions

2011
Mineralocorticoid receptor agonists induce mouse aortic aneurysm formation and rupture in the presence of high salt.
    Arteriosclerosis, thrombosis, and vascular biology, 2013, Volume: 33, Issue:7

    Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Aortic Aneurysm, Abdominal; Aortic Aneurysm, Thoracic; Aortic Rupture; Apoptosis; Blood Pressure; Desoxycorticosterone; Disease Models, Animal; Elastin; Enalapril; Eplerenone; Losartan; Male; Mice; Mice, Inbred C57BL; Mineralocorticoid Receptor Antagonists; Muscle, Smooth, Vascular; Oxidative Stress; Receptors, Mineralocorticoid; Sodium Chloride, Dietary; Spironolactone; Time Factors

2013
Biotransformation of the mineralocorticoid receptor antagonists spironolactone and canrenone by human CYP11B1 and CYP11B2: Characterization of the products and their influence on mineralocorticoid receptor transactivation.
    The Journal of steroid biochemistry and molecular biology, 2016, Volume: 163

    Topics: Biotransformation; Canrenone; Cloning, Molecular; Cortodoxone; Cytochrome P-450 CYP11B2; Desoxycorticosterone; Eplerenone; Escherichia coli; Humans; Kinetics; Mineralocorticoid Receptor Antagonists; Receptors, Mineralocorticoid; Recombinant Proteins; Spironolactone; Steroid 11-beta-Hydroxylase; Transcriptional Activation

2016
Aldosterone and dexamethasone activate African lungfish mineralocorticoid receptor: Increased activation after removal of the amino-terminal domain.
    The Journal of steroid biochemistry and molecular biology, 2022, Volume: 215

    Topics: Aldosterone; Animals; Corticosterone; Cortodoxone; Desoxycorticosterone; Dexamethasone; Eplerenone; Fish Proteins; Fishes; Gene Expression; Hydrocortisone; Kinetics; Progesterone; Protein Domains; Protein Engineering; Receptors, Glucocorticoid; Receptors, Mineralocorticoid; Recombinant Proteins; Spironolactone; Triamcinolone

2022
Effect of 11-Deoxycorticosterone in the Transcriptomic Response to Stress in Rainbow Trout Skeletal Muscle.
    Genes, 2023, 02-17, Volume: 14, Issue:2

    Topics: Animals; Desoxycorticosterone; Eplerenone; Hydrocortisone; Mifepristone; Muscle, Skeletal; Oncorhynchus mykiss; Transcriptome

2023